The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
WHO-EORTC classification for cutaneous lymphomas
Willemze, R. (2005) · Blood · doi:10.1182/blood-2004-09-3502 · Cited by 3,803
Kolb, H., Schattenberg, A., Goldman, J., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., & Niederwieser, D. (1995) · Blood · doi:10.1182/blood.v86.5.2041.bloodjournal8652041 · Cited by 1,934
Olsen, E., Vonderheid, E., Pimpinelli, N., Willemze, R., Kim, Y., Knobler, R., Zackheim, H., Duvic, M., Estrach, T., Lamberg, S., et al. (2007) · Blood · doi:10.1182/blood-2007-03-055749 · Cited by 1,429
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
Zacks, C. M., Abbott, R. L., & Fine, M. (1990) · Cornea · doi:10.1097/00003226-199004000-00002 · Cited by 1,234
Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy
Edelson, R., Berger, C., Gasparro, F., Jegasothy, B., Heald, P., Wintroub, B., Vonderheid, E., Knobler, R., Wolff, K., Plewig, G., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702053160603 · Cited by 1,199
Olsen, E. A., Kim, Y. H., Kuzel, T. M., Pacheco, T. R., Foss, F. M., Parker, S., Frankel, S. R., Chen, C., Ricker, J. L., Arduino, J. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.2434 · Cited by 1,055
Thiers, B. H. (2008) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70989-4 · Cited by 974
Agar, N. S., Wedgeworth, E., Crichton, S., Mitchell, T. J., Cox, M., Ferreira, S., Robson, A., Calonje, E., Stefanato, C. M., Wain, E. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.7665 · Cited by 853
The evolution of thalidomide and its IMiD derivatives as anticancer agents
Bartlett, J. B., Dredge, K., & Dalgleish, A. G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1323 · Cited by 809
Piekarz, R. L., Frye, R., Turner, M., Wright, J. J., Allen, S. L., Kirschbaum, M. H., Zain, J., Prince, H. M., Leonard, J. P., Geskin, L. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6150 · Cited by 740
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases
Bradford, P. T., Devesa, S. S., Anderson, W. F., & Toro, J. R. (2009) · Blood · doi:10.1182/blood-2008-10-184168 · Cited by 709
Duvic, M., Hymes, K., Heald, P., Breneman, D., Martin, A. G., Myskowski, P., Crowley, C., Yocum, R. C., & for Members of the Bexarotene Worldwide Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.9.2456 · Cited by 706
Self-citationOlsen, E. A., Whittaker, S., Kim, Y. H., Duvic, M., Prince, H. M., Lessin, S. R., Wood, G. S., Willemze, R., Demierre, M.-F., Pimpinelli, N., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.0630 · Cited by 666
Self-citationWhittaker, S. J., Demierre, M.-F., Kim, E. J., Rook, A. H., Lerner, A., Duvic, M., Scarisbrick, J., Reddy, S., Robak, T., Becker, J. C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.9066 · Cited by 664
Kim, Y. H., Liu, H. L., Mraz-Gernhard, S., Varghese, A., & Hoppe, R. T. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.7.857 · Cited by 653
Olsen, E., Duvic, M., Frankel, A., Kim, Y., Martin, A., Vonderheid, E., Jegasothy, B., Wood, G., Gordon, M., Heald, P., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.376 · Cited by 609
Defining early mycosis fungoides
Pimpinelli, N., Olsen, E. A., Santucci, M., Vonderheid, E., Haeffner, A. C., Stevens, S., Burg, G., Cerroni, L., Dreno, B., Glusac, E., et al. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.08.057 · Cited by 550
Incidence of Cutaneous T-Cell Lymphoma in the United States, 1973-2002
Criscione, V. D., & Weinstock, M. A. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.7.854 · Cited by 527
Campbell, J. J., Clark, R. A., Watanabe, R., & Kupper, T. S. (2010) · Blood · doi:10.1182/blood-2009-11-251926 · Cited by 519
Reiss, Y., Proudfoot, A. E., Power, C. A., Campbell, J. J., & Butcher, E. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1541 · Cited by 517
Vonderheid, E. C., Bernengo, M. G., Burg, G., Duvic, M., Heald, P., Laroche, L., Olsen, E., Pittelkow, M., Russell-Jones, R., Takigawa, M., et al. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.118538 · Cited by 493
Duvic, M. A., Martín, Á. G., Kim, Y. H., Olsen, E. A., Wood, G. S., Crowley, C., & Yocum, R. C. (2001) · PubMed · Cited by 489
Inflammatory Skin Diseases, T Cells, and Immune Surveillance
Robert, C., & Kupper, T. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912093412407 · Cited by 475
Graft-versus-leukemia reactions in allogeneic chimeras
Kolb, H.-J., Schmid, C., Barrett, A. J., & Schendel, D. J. (2004) · Blood · doi:10.1182/blood-2003-02-0342 · Cited by 397
Lundin, J., Hagberg, H., Repp, R., Cavallin-Ståhl, E., Fredén, S., Juliusson, G., Rosenblad, E., Tjønnfjord, G., Wiklund, T., & Österborg, A. (2003) · Blood · doi:10.1182/blood-2002-09-2802 · Cited by 390
The Pathogenesis of Mycosis Fungoides
Girardi, M., Heald, P. W., & Wilson, L. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032810 · Cited by 389
Clark, R. A., Watanabe, R., Teague, J. E., Schlapbach, C., Tawa, M. C., Adams, N., Dorosario, A. A., Chaney, K. S., Cutler, C. S., LeBoeuf, N. R., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003008 · Cited by 367
Wood, G. S., Tung, R. M., Heaffner, A. C., Crooks, C. F., Liao, S., Orozco, R., Veelken, H., Kadin, M. E., Koh, H., Heald, P., et al. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12389114 · Cited by 349
Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model
Hu, Y., Turner, M. J., Shields, J., Gale, M. S., Hutto, E., Roberts, B. L., Siders, W. M., & Kaplan, J. M. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03115.x · Cited by 335
Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis
Diamandidou, E., Colome-Grimmer, M., Fayad, L., Duvic, M., & Kurzrock, R. (1998) · Blood · doi:10.1182/blood.v92.4.1150 · Cited by 334
van Doorn, R., Scheffer, E., & Willemze, R. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.2.191 · Cited by 331
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects
Burg, G., Kempf, W., Cozzio, A., Feit, J., Willemze, R., S. Jaffe, E., Dummer, R., Berti, E., Cerroni, L., Chimenti, S., et al. (2005) · Journal of Cutaneous Pathology · doi:10.1111/j.0303-6987.2005.00495.x · Cited by 330
Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells
Olkhanud, P. B., Baatar, D., Bodogai, M., Hakim, F., Gress, R., Anderson, R. L., Deng, J., Xu, M., Briest, S., & Biragyn, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4619 · Cited by 312
Long-term Outcomes of 1,263 Patients with Mycosis Fungoides and Sézary Syndrome from 1982 to 2009
Talpur, R., Singh, L., Daulat, S., Liu, P., Seyfer, S., Trynosky, T., Wei, W., & Duvic, M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0604 · Cited by 289
Zinzani, P. L., Musuraca, G., Tani, M., Stefoni, V., Marchi, E., Fina, M., Pellegrini, C., Alinari, L., Derenzini, E., de Vivo, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.4207 · Cited by 280
Yoo, E. K., Rook, A. H., Elenitsas, R., Gasparro, F. P., & Vowels, B. R. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12329711 · Cited by 270
Increased CCR4 Expression in Cutaneous T Cell Lymphoma
Ferenczi, K., Fuhlbrigge, R. C., Kupper, T. S., Pinkus, J. L., & Pinkus, G. S. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.19610.x · Cited by 265
Vergier, B., Muret, A. D., Beylot-Barry, M., Vaillant, L., Ekouévi, D. K., Chêne, G., Carlotti, A., Franck, N., Dechelotte, P., Souteyrand, P., et al. (2000) · PubMed · doi:10.1182/blood.v95.7.2212 · Cited by 263
The effects of ultraviolet radiation on the human immune system: EFFECTS OF UV ON THE IMMUNE SYSTEM
Duthie, Kimber, & Norval (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02898.x · Cited by 245
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)
Ralfkiaer, U., Hagedorn, P. H., Bangsgaard, N., Løvendorf, M. B., Ahler, C. B., Svensson, L., Kopp, K. L., Vennegaard, M. T., Lauenborg, B., Zibert, J. R., et al. (2011) · Blood · doi:10.1182/blood-2011-06-358382 · Cited by 240
Prince, H. M., Duvic, M., Martin, A., Sterry, W., Assaf, C., Sun, Y., Straus, D., Acosta, M., & Negro-Vilar, A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.2386 · Cited by 233
Shapiro, P. E., & Pinto, F. J. (1994) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199407000-00001 · Cited by 232
Robertson, M. J., Kahl, B. S., Vose, J. M., de Vos, S., Laughlin, M., Flynn, P. J., Rowland, K., Cruz, J. C., Goldberg, S. L., Musib, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.3146 · Cited by 232
van Doorn, R., Zoutman, W. H., Dijkman, R., de Menezes, R. X., Commandeur, S., Mulder, A. A., van der Velden, P. A., Vermeer, M. H., Willemze, R., Yan, P. S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.353 · Cited by 228
Zhang, C., Hazarika, P., Ni, X., Weidner, D. A., & Duvic, M. A. (2002) · PubMed · Cited by 223
Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases
Benner, M. F., Jansen, P. M., Vermeer, M. H., & Willemze, R. (2012) · Blood · doi:10.1182/blood-2011-08-376319 · Cited by 215
Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T‐cell lymphoma
Wollina, U., Dummer, R., Brockmeyer, N. H., Konrad, H., Busch, J. ‐., Kaatz, M., Knopf, B., Koch, H., & Hauschild, A. (2003) · Cancer · doi:10.1002/cncr.11593 · Cited by 214
Gottlieb, S. L., Wolfe, J. T., Fox, F. E., DeNardo, B. J., Macey, W. H., Bromley, P. G., Lessin, S. R., & Rook, A. H. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90119-x · Cited by 209
Kim, Y. H., Duvic, M., Obitz, E., Gniadecki, R., Iversen, L., Österborg, A., Whittaker, S., Illidge, T. M., Schwarz, T., Kaufmann, R., et al. (2007) · Blood · doi:10.1182/blood-2006-12-062877 · Cited by 204
Massone, C., Kodama, K., Kerl, H., & Cerroni, L. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000153121.57515.c6 · Cited by 203
The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells
Bernengo, M. G., Novelli, M., Quaglino, P., Lisa, F., De Matteis, A., Savoia, P., Cappello, N., & Fierro, M. T. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04014.x · Cited by 201
Kempf, W., Ostheeren-Michaelis, S., Paulli, M., Lucioni, M., Wechsler, J., Audring, H., Assaf, C., Rüdiger, T., Willemze, R., Meijer, C. J. L. M., et al. (2008) · Archives of Dermatology · doi:10.1001/archdermatol.2008.46 · Cited by 201
Absence of CD26 Expression Is a Useful Marker for Diagnosis of T-Cell Lymphoma in Peripheral Blood
Jones, D., Dang, N. H., Duvic, M., Washington, L. T., & Huh, Y. O. (2001) · American Journal of Clinical Pathology · doi:10.1309/u1y6-j4ag-5m4m-7ayv · Cited by 201
Nielsen, M., Kæstel, C., Eriksen, K., Woetmann, A., Stokkedal, T., Kaltoft, K., Geisler, C., Röpke, C., & Ødum, N. (1999) · Leukemia · doi:10.1038/sj.leu.2401415 · Cited by 197
Maren, W., Blum, A., Frank, E., Röcken, M., & Berneburg, M. (2004) · Acta Dermato-Venereologica · doi:10.1080/00015550410026948 · Cited by 196
Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas
Mao, X., Orchard, G., Lillington, D. M., Russell-Jones, R., Young, B. D., & Whittaker, S. J. (2003) · Blood · doi:10.1182/blood-2002-08-2434 · Cited by 194
Lessin, S. R., Duvic, M. A., Guitart, J., Pandya, A. G., Strober, B. E., Olsen, E. A., Hull, C. M., Knobler, E. H., Rook, A. H., Kim, E. J., et al. (2012) · JAMA Dermatology · doi:10.1001/2013.jamadermatol.541 · Cited by 192
Haghighi, B., Smoller, B. R., LeBoit, P. E., Warnke, R. A., Sander, C. A., & Kohler, S. (2000) · Modern Pathology · doi:10.1038/modpathol.3880088 · Cited by 188
The patch stage of mycosis fungoides Criteria for histologic diagnosis
Sanchez, J. L., & Ackerman, B. A. (1979) · The American Journal of Dermatopathology · doi:10.1097/00000372-197900110-00002 · Cited by 187
Williams, D. P., Snider, C. E., Strom, T. B., & Murphy, J. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38482-0 · Cited by 185
Optimizing bexarotene therapy for cutaneous T-cell lymphoma
Talpur, R., Ward, S., Apisarnthanarax, N., Breuer-McHam, J., & Duvic, M. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.124607 · Cited by 185
Reassessment of Histologic Parameters in the Diagnosis of Mycosis Fungoides
Smoller, B. R., Bishop, K., Glusac, E., Kim, Y. H., & Hendrickson, M. (1995) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199512000-00009 · Cited by 181
Saed, G., Fivenson, D. P., Naidu, Y., & Nickoloff, B. J. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12388985 · Cited by 177
Bernengo, M. G., Quaglino, P., Comessatti, A., Ortoncelli, M., Novelli, M., Lisa, F., & Fierro, M. T. (2007) · Haematologica · doi:10.3324/haematol.11127 · Cited by 174
Sors, A., Jean-Louis, F., Pellet, C., Laroche, L., Dubertret, L., Courtois, G., Bachelez, H., & Michel, L. (2006) · Blood · doi:10.1182/blood-2005-06-2536 · Cited by 174
Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma
Yawalkar, N., Ferenczi, K., Jones, D. A., Yamanaka, K., Suh, K.-Y., Sadat, S., & Kupper, T. S. (2003) · Blood · doi:10.1182/blood-2003-04-1044 · Cited by 172
Prognostic factor analysis in mycosis fungoides/Sézary syndrome
Diamandidou, E., Colome, M., Fayad, L., Duvic, M., & Kurzrock, R. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70079-4 · Cited by 172
Low-Dose Palliative Radiotherapy for Cutaneous B- and T-Cell Lymphomas
Neelis, K. J., Schimmel, E. C., Vermeer, M. H., Senff, N. J., Willemze, R., & Noordijk, E. M. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.06.1918 · Cited by 172
Olsen, E. A., Rook, A. H., Zic, J., Kim, Y., Porcu, P., Querfeld, C., Wood, G., Demierre, M.-F., Pittelkow, M., Wilson, L. D., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.08.037 · Cited by 169
Self-citationPhase II Study of Recombinant Human Interferon Gamma for Treatment of Cutaneous T-Cell Lymphoma
Kaplan, E. H., Rosen, S. T., Norris, D. B., Roenigk, H. H., Saks, S. R., & Bunn, P. A. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.3.208 · Cited by 168
Pancake, B. A., Zucker‐Franklin, D., & Coutavas, E. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117697 · Cited by 163
Mao, X., Lillington, D., Scarisbrick, J. J., Mitchell, T., Czepulkowski, B., Russell-Jones, R., Young, B., & Whittaker, S. J. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04966.x · Cited by 163
Inhibition of Histone Deacetylation: A Strategy for Tumor Radiosensitization
Camphausen, K., & Tofilon, P. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.6202 · Cited by 162
Sommer, V. H., Clemmensen, O. J., Nielsen, O., Wasik, M., Lovato, P., Brender, C., Eriksen, K. W., Woetmann, A., Kaestel, C. G., Nissen, M. H., et al. (2004) · Leukemia · doi:10.1038/sj.leu.2403385 · Cited by 162
Gemcitabine as frontline treatment for cutaneous T‐cell lymphoma: Phase II study of 32 patients
Marchi, E., Alinari, L., Tani, M., Stefoni, V., Pimpinelli, N., Berti, E., Pagano, L., Bernengo, M. G., Zaja, F., Rupoli, S., et al. (2005) · Cancer · doi:10.1002/cncr.21449 · Cited by 161
Scarabello, A., Leinweber, B., Ardigó, M., Rütten, A., Feller, A. C., Kerl, H., & Cerroni, L. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200210000-00002 · Cited by 161
Fraser-Andrews, E. A., Woolford, A. J., Russell-Jones, R., Whittaker, S. J., & Seed, P. T. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00830.x · Cited by 161
FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival
Gjerdrum, L. M., Woetmann, A., Odum, N., Burton, C. M., Rossen, K., Skovgaard, G. L., Ryder, L. P., & Ralfkiaer, E. (2007) · Leukemia · doi:10.1038/sj.leu.2404913 · Cited by 158
Narrowband (311-nm) UV-B Therapy for Small Plaque Parapsoriasis and Early-Stage Mycosis Fungoides
Hofer, A., Cerroni, L., Kerl, H., & Wolf, P. S. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.11.1377 · Cited by 155
Regulation of Leukocyte‐Endothelial Interactions by Glucocorticoids
Pitzalis, C., Pipitone, N., & Perretti, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04208.x · Cited by 152
Treatment of patients with advanced mycosis fungoides and Sézary syndrome with alemtuzumab
Kennedy, G., Seymour, J. F., Wolf, M., Januszewicz, H., Davison, J., McCormack, C. J., Ryan, G., & Prince, H. M. (2003) · European Journal Of Haematology · doi:10.1034/j.1600-0609.2003.00143.x · Cited by 152
Kakinuma, T., Sugaya, M., Nakamura, K., Kaneko, F., Wakugawa, M., Matsushima, K., & Tamaki, K. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.132 · Cited by 151
Mycosis fungoides: The great imitator
Zackheim, H. S., & McCalmont, T. H. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.124696 · Cited by 150
Querfeld, C. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.3.305 · Cited by 150
Self-citationSamimi, S. S., Benoit, B. M., Evans, K. G., Wherry, E. J., Showe, L. C., Wysocka, M., & Rook, A. H. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.200 · Cited by 150
Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients
Zackheim, H. S., Kashani–Sabet, M., & McMillan, A. (2003) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(03)01591-3 · Cited by 149
Interferon in the Treatment of Cutaneous T-cell Lymphoma
Olsen, E. A., & Bunn, P. A. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30060-1 · Cited by 144
Broder, S., & Bunn, P. A. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92785-9 · Cited by 143
Santucci, M., Biggeri, A., Feller, A. C., Massi, D., & Burg, G. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200001000-00005 · Cited by 141
Harmon, C. B., Witzig, T. E., Katzmann, J. A., & Pittelkow, M. R. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90605-2 · Cited by 139
Clonal heterogeneity in mycosis fungoides and its relationship to clinical course
Vega, F., Luthra, R., Medeiros, L. J., Dunmire, V., Lee, S., Duvic, M. A., & Jones, D. M. (2002) · Blood · doi:10.1182/blood.v100.9.3369 · Cited by 137
Isotretinoin and Cutaneous Helper T-Cell Lymphoma (Mycosis Fungoides)
Kessler, J. F., Jones, S. E., Levine, N., Lynch, P. J., Booth, A. R., & Meyskens, F. L. (1987) · Archives of Dermatology · doi:10.1001/archderm.1987.01660260071016 · Cited by 137
Antitumor activity of DAB389 IL-2 fusion toxin in mycosis fungoides
Saleh, M. N., LeMaistre, C. F., Kuzel, T. M., Foss, F. M., Platanias, L. C., Schwartz, G. N., Ratain, M. J., Rook, A. H., Freytes, C. O., Craig, F. E., et al. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70403-7 · Cited by 137
Horwitz, S. M., Kim, Y. H., Foss, F. M., Zain, J. M., Myskowski, P. L., Lechowicz, M. J., Fisher, D. C., Shustov, A. R., Bartlett, N. L., Delioukina, M. L., et al. (2012) · Blood · doi:10.1182/blood-2011-11-390211 · Cited by 136
Self-citationFrequent Abnormalities of the P15 and P16 Genes in Mycosis Fungoides and Sezary Syndrome
Scarisbrick, J. J., Woolford, A. J. ‐., Calonje, E. J., Photiou, A., Ferreira, S., Orchard, G. E., Russell‐Jones, R., & Whittaker, S. J. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01682.x · Cited by 133
Wilson, L. D., Jones, G. W., Kim, D. S., Rosenthal, D., Christensen, I. R., Edelson, R. L., HEALD, P. W., & Kacinski, B. M. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.105510 · Cited by 132
Differential Expression of Programmed Death-1 (PD-1) in Sézary Syndrome and Mycosis Fungoides
Çetinözman, F., Jansen, P. M., Vermeer, M. H., & Willemze, R. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2012.2089 · Cited by 132
Thurber, S. E., Zhang, B. M., Kim, Y. H., Schrijver, I., Zehnder, J. L., & Köhler, S. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.06.004 · Cited by 130
Mast cells play a protumorigenic role in primary cutaneous lymphoma
Rabenhorst, A., Schlaak, M. S., Heukamp, L. C., Förster, A., Theurich, S., von Bergwelt‐Baildon, M., Büttner, R., Kurschat, P., Mauch, C., Roers, A., et al. (2012) · Blood · doi:10.1182/blood-2012-03-415638 · Cited by 130
Bexarotene therapy for mycosis fungoides and Sézary syndrome
Abbott, R. A., Whittaker, S. J., Morris, S., Russell‐Jones, R., Hung, T., Bashir, S. J., & Scarisbrick, J. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09037.x · Cited by 130
Photopheresis therapy for cutaneous T-cell lymphoma
Duvic, M. A., Hester, J. P., & Lemak, N. A. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90683-0 · Cited by 128
Gomez Orbaneja, J., Díez, L. I., Lozano, J. L. S., et al. (1976) · Contact Dermatitis · doi:10.1111/j.1600-0536.1976.tb03012.x · Cited by 125
Wood, G. S., Abel, E., Hoppe, R. T., et al. (1986) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(86)70124-2 · Cited by 125
Scarisbrick, J. J., Woolford, A. J. ‐., Russell‐Jones, R., & Whittaker, S. J. (2000) · Blood · doi:10.1182/blood.v95.9.2937.009k15_2937_2942 · Cited by 125
Immunopathology of cutaneous T-cell lymphomas.
Nasu, K., Said, J. W., Vonderheid, E. C., Olerud, J. E., Sako, D., & Kadin, M. E. (1985) · PubMed Central · Cited by 124
Mycosis fungoides: radiation therapy
Hoppe, R. T. (2003) · Dermatologic Therapy · doi:10.1111/j.1396-0296.2003.01647.x · Cited by 123
Suchin, K. R., Cucchiara, A. J., Gottleib, S. L., Wolfe, J. T., DeNardo, B. J., Macey, W. H., Bromley, P. G., Vittorio, C. C., & Rook, A. H. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.8.1054 · Cited by 123
Interferon in the treatment of cutaneous T-cell lymphoma
Olsen, E. A. (2003) · Dermatologic Therapy · doi:10.1111/j.1396-0296.2003.01643.x · Cited by 122
Kallinich, T., Muche, J. M., Qin, S., Sterry, W., Audring, H., & Kroczek, R. A. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12555.x · Cited by 121
Kim, Y. H., Girardi, M., Duvic, M. A., Kuzel, T. M., Link, B. K., Pinter‐Brown, L. C., & Rook, A. H. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.12.052 · Cited by 121
Guitart, J., Kennedy, J., Ronan, S., Chmiel, J. S., Hsiegh, Y., & Variakojis, D. (2001) · Journal of Cutaneous Pathology · doi:10.1034/j.1600-0560.2001.028004174.x · Cited by 120
Folliculotropic mycosis fungoides: Clinicopathological features and outcome in a series of 20 cases
Muniesa, C., Estrach, T., Pujol, R. M., Gallardo, F., García‐Muret, P., Climent, F., & Servitje, O. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.03.014 · Cited by 119
Topical mechiorethamine therapy for early stage mycosis fungoides
Ramsay, D. L., Halperin, P. S., & Zeleniuch‐Jacquotte, A. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)70223-6 · Cited by 118
Wilson, L. D., Kacinski, B. M., & Jones, G. W. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00553-1 · Cited by 118
TREATMENT OF CUTANEOUS T-CELL LYMPHOMA (MYCOSIS FUNGOIDES) WITH 13-CIS-RETINOIC ACID
Jf, K., Levine, N. S., Meyskens, F., Lynch, P., & Jones, S. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92136-0 · Cited by 117
Wang, E. S., O’Connor, O. A., She, Y., Zelenetz, A. D., Sirotnak, F. M., & Moore, M. A. S. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000077124 · Cited by 116
CDKN2A–CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma
Laharanne, E., Chevret, E., Idrissi, Y., Gentil, C., Longy, M., Ferrer, J., Dubus, P. R., Jouary, T., Vergier, B., Beylot-Barry, M., et al. (2010) · Modern Pathology · doi:10.1038/modpathol.2009.196 · Cited by 115
Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome
Krejsgaard, T., Ødum, N., Geisler, C., Wasik, M. A., & Woetmann, A. (2011) · Leukemia · doi:10.1038/leu.2011.237 · Cited by 114
Wozniak, M. B., Villuendas, R., Bischoff, J. R., Aparicio, C. B., Martínez-Leal, J. F., de la Cueva, P., Rodríguez, M. E., Herreros, B., Martín-Pérez, D., Longo, M. I., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.013870 · Cited by 114
Dummer, R., Quaglino, P., Becker, J. C., Hasan, B., Karrasch, M., Whittaker, S. J., Morris, S. L., Weichenthal, M., Stadler, R., Bagot, M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.8065 · Cited by 113
Vermeer, M. H., van Doorn, R., Dukers, D. F., Bekkenk, M. W., Meijer, C. J. L. M., & Willemze, R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.23.4322 · Cited by 113
Talpur, R., Jones, D. M., Alencar, A. J., Apisarnthanarax, N., Herne, K. L., Yang, Y., & Duvic, M. A. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700122 · Cited by 112
Revisiting Low-Dose Total Skin Electron Beam Therapy in Mycosis Fungoides
Harrison, C., Young, J. W., Navi, D., Riaz, N., Lingala, B., Kim, Y. H., & Hoppe, R. T. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.01.023 · Cited by 110
HLA-DR5 and DQB1*03 Class II Alleles Are Associated With Cutaneous T-Cell Lymphoma
Jackow, C. M., Breuer-McHam, J., Friss, A., Alvear, J., Reveille, J. R., & Duvic, M. A. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12363352 · Cited by 110
Extracorporeal photopheresis and interferon-α in advanced cutaneous T-cell lymphoma
Dippel, E., Schrag, H.-J., Goerdt, S., & Orfanos, C. E. (1997) · The Lancet · doi:10.1016/s0140-6736(05)66242-3 · Cited by 108
Sugaya, M., Miyagaki, T., Ohmatsu, H., Suga, H., Kai, H., Kamata, M., Fujita, H., Asano, Y., Tada, Y., Kadono, T., et al. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.07.007 · Cited by 108
p16INK4a Gene Alterations Are Frequent in Lesions of Mycosis Fungoides
Navas, I. C., Ortiz-Romero, P. L., Villuendas, R., Martínez, P., García, C., Gómez, E., Rodriguez, J. L., García, D., Vanaclocha, F., Iglesias, L., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65028-6 · Cited by 107
Chong, B. F., Wilson, A. J., Gibson, H. M., Hafner, M. S., Luo, Y. H., Hedgcock, C. J., & Wong, H. K. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0610 · Cited by 106
Thomas, T. O., Agrawal, P., Guitart, J., Rosen, S. T., RADEMAKER, A. W., Querfeld, C., Hayes, J. P., Kuzel, T. M., & Mittal, B. B. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.05.034 · Cited by 105
Self-citationQuerfeld, C., Mehta, N., Rosen, S. T., Guitart, J., RADEMAKER, A. W., Gerami, P., & Kuzel, T. M. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190903216770 · Cited by 105
Self-citationDereure, O., Levi, E., Kadin, M. E., & Vonderheid, E. C. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01794.x · Cited by 104
Tiffon, C., Adams, J. E., van der Fits, L., Wen, S., Townsend, P. A., Ganesan, A., Hodges, E., Vermeer, M. H., & Packham, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01188.x · Cited by 103
Berger, C. L., Hoffmann, K. E., Vasquez, J. G., Mane, S., Lewis, J. M., Filler, R. B., Lin, A., Zhao, H., Durazzo, T. S., Waldman, A., et al. (2010) · Blood · doi:10.1182/blood-2009-11-256040 · Cited by 101
Duvic, M. A., Olsen, E. A., Breneman, D., Pacheco, T. R., Parker, S. R. S., Vonderheid, E. C., Abuav, R., Ricker, J. L., Rizvi, S., Chen, C., et al. (2009) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2009.n.082 · Cited by 100
Pope, E., Weitzman, S. S., Ngan, B., Walsh, S. R., Morel, K. D., Williams, J. V., Stein, S. L., Garzón, M. C., Knobler, E. H., Lieber, C., et al. (2010) · Journal of Cutaneous Medicine and Surgery · doi:10.2310/7750.2009.08091 · Cited by 99
Whittaker, S. J., Ortiz-Romero, P. L., Dummer, R., Ranki, A., Hasan, B., Meulemans, B., Gellrich, S., Knobler, R., Stadler, R., & Karrasch, M. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11156.x · Cited by 99
Ralfkiaer, E. M., Wantzin, G. L., Mason, D. Y., HOU-JENSEN, K., Stein, H., & Thomsen, K. (1985) · American Journal of Clinical Pathology · doi:10.1093/ajcp/84.5.610 · Cited by 99
Straus, D. J., Duvic, M. A., Kuzel, T. M., Horwitz, S. M., Demierre, M., Myskowski, P. L., & Steckel, S. (2007) · Cancer · doi:10.1002/cncr.22596 · Cited by 97
Self-citationMorschhauser, F., Seymour, J. F., Kluin‐Nelemans, H. C., Grigg, A., Wolf, M., Pfreundschuh, M. G., Tilly, H., Raemaekers, J. M. M., Veer, M. B. V., Milpied, N. J., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm463 · Cited by 97
Wilson, L. D., Licata, A. L., Braverman, I. M., Edelson, R. L., HEALD, P. W., Feldman, A. M., & Kacinski, B. M. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00073-8 · Cited by 95
JUMBOU, Nguyen, TESSIER, LEGOUX, & DRÉNO (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02704.x · Cited by 94
Rook, A. H., Prystowsky, M. B., Cassin, M., Boufal, M., & Lessin, S. R. (1991) · Archives of Dermatology · doi:10.1001/archderm.127.10.1535 · Cited by 94
Delfau‐Larue, M., Dalac, S., Lepage, É., Petrella, T., Wechsler, J., Farcet, J., & Bagot, M. (1998) · Blood · doi:10.1182/blood.v92.9.3376 · Cited by 92
Bergman, R., Faclieru, D., Sahar, D., Sander, C. A., Kerner, H., Ben-Aryeh, Y., Manov, L., Hertz, E., Sabo, E., & Friedman‐Birnbaum, R. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70003-9 · Cited by 90
Querfeld, C., Rizvi, M. A., Kuzel, T. M., Guitart, J., RADEMAKER, A. W., Sabharwal, S. S., Krett, N. L., & Rosen, S. T. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700322 · Cited by 89
Self-citationCutaneous T-cell lymphoma treatment using bexarotene and PUVA: A case series
Singh, F., & Lebwohl, M. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.05.010 · Cited by 85
Molin, L., Thomsen, K., VOLDEN, G., Aronsson, A., HAMMAR, H., HELLBE, L., Wantzin, G., & Roupe, G. (1987) · Acta Dermato Venereologica · doi:10.2340/0001555567232236 · Cited by 84
Photochemotherapy for Mycosis Fungoides
Lowe, N. J. (1979) · Archives of Dermatology · doi:10.1001/archderm.1979.04010010022007 · Cited by 79
Significance of circulating T-cell clones in Sezary syndrome
Ortonne, N., Huet, D., Gaudez, C., Marie‐Cardine, A., Schiavon, V., Bagot, M., Musette, P., & Bensussan, A. (2006) · Blood · doi:10.1182/blood-2005-10-4239 · Cited by 78
Siders, W., Shields, J. D., Garron, C., Hu, Y., Boutin, P., Shankara, S., Weber, W. D., Roberts, B., & Kaplan, J. M. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428191003777963 · Cited by 77
Chang, D.-K., Sui, J., Geng, S., Muvaffak, A., Bai, M., Fuhlbrigge, R. C., Lo, A. S., Yammanuru, A., Hubbard, L., Sheehan, J., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0278 · Cited by 75
Baron, F., & Storb, R. F. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.011 · Cited by 73
Santucci, M., Biggeri, A., Feller, A. C., & Burg, G. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.4.497 · Cited by 72
Duvic, M. A., Sherman, M. L., Wood, G. S., Kuzel, T. M., Olsen, E. A., Foss, F. M., Laliberte, R. J., Ryan, J. L., Zonno, K., & Rook, A. H. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.06.038 · Cited by 72
Miyagaki, T., Sugaya, M., Suga, H., Ohmatsu, H., Fujita, H., Asano, Y., Tada, Y., Kadono, T., & Sato, S. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04495.x · Cited by 71
Kelly‐Sell, M. J., Kim, Y. H., Straus, S., Benoit, B. M., Harrison, C., Sutherland, K., Armstrong, R. J., Weng, W., Showe, L. C., Wysocka, M., et al. (2012) · American Journal of Hematology · doi:10.1002/ajh.23112 · Cited by 70
Yagi, H., Seo, N., Ohshima, A., Itoh, T., Itoh, N., Horibe, T., Yoshinari, Y., Takigawa, M., & Hashizume, H. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213267.92349.59 · Cited by 70
Treatment of cutaneous lymphoma with etretinate
Claudy, A., Rouchouse, B., Boucheron, S., et al. (1983) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1983.tb03991.x · Cited by 70
Yano, H., Ishida, T., Inagaki, A., Ishii, T., Ding, J., Kusumoto, S., Komatsu, H., Iida, S., Inagaki, H., & Ueda, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1324 · Cited by 70
Dummer, R., Beyer, M., Hymes, K. B., Epping, M. T., Bernards, R., Steinhoff, M., Sterry, W., Kerl, H., Heath, K., Ahern, J. D., et al. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.656625 · Cited by 69
Jones, C. L., Wain, E. M., Chu, C.-C., Tosi, I., Foster, R., McKenzie, R. C. T., Whittaker, S. J., & Mitchell, T. J. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.301 · Cited by 66
BCL2 and JUNB abnormalities in primary cutaneous lymphomas
Mao, X., Orchard, G. E., Lillington, D. M., Child, F. J., Vonderheid, E. C., Nowell̀, P. C., Bagot, M., Bensussan, A., Russell‐Jones, R., Young, B. D., et al. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06106.x · Cited by 65
Bisaccia, E., Gonzalez, J., Palangio, M., Schwartz, J. E., & Klainer, A. S. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.104852 · Cited by 65
Richardson, S. K., Newton, S. B., Bach, T. L., Budgin, J. B., Benoit, B. M., Lin, J. H., Yoon, J. S., Wysocka, M., Abrams, C. S., & Rook, A. H. (2007) · American Journal of Hematology · doi:10.1002/ajh.20952 · Cited by 64
Mao, X., Orchard, G. E., Mitchell, T. J., Oyama, N., Russell‐Jones, R., Vermeer, M. H., Willemze, R., van Doorn, R., Tensen, C. P., Young, B. D., et al. (2008) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2007.00924.x · Cited by 62
Ermertcan, A. T., Öztürk, F., & Gündüz, K. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04049.x · Cited by 62
Nikolaou, V. A., Papadavid, E., Katsambas, A. D., Stratigos, A., Marinos, L., Anagnostou, D., & Antoniou, C. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09301.x · Cited by 61
Dereure, O., Portalès, P., Clot, J., & Guilhou, J. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03889.x · Cited by 61
Ni, X., Hazarika, P., Zhang, C., Talpur, R., & Duvic, M. A. (2001) · PubMed · Cited by 60
Occupational Risk Factors for Mycosis Fungoides: A European Multicenter Case-Control Study
Morales‐Suárez‐Varela, M., Olsen, J., Johansen, P., Kærlev, L., Guénel, P., Arveux, P., Wingren, G. B., Hardell, L., Ahrens, W., Stang, A., et al. (2004) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000116819.01813.8c · Cited by 59
Delfau‐Larue, M., Petrella, T., Lahet, C., Lebozec, C.-D., Bagot, M., Roudot‐Thoraval, F., Dalac, S., Farcet, J., & Wechsler, J. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199802)184:2<185::aid-path997>3.0.co;2-9 · Cited by 59
T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28
Nickoloff, B. J., Nestle, F. O., Zheng, X., & Turka, L. A. (1994) · Blood · doi:10.1182/blood.v83.9.2580.2580 · Cited by 57
Sarantopoulos, G. P., Palla, B., SAID, J. W., Kinney, M. C., Swerdlow, S. M., Willemze, R., & Binder, S. W. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcpx4bxtp2qbrko · Cited by 56
The Role for Interleukin‐12 Therapy of Cutaneous T Cell Lymphoma
Rook, A. H., Zaki, M. H., Wysocka, M., Wood, G. S., Duvic, M. A., Showe, L. C., Foss, F. M., Shapiro, M. B., Kuzel, T. M., Olsen, E. A., et al. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03721.x · Cited by 56
Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study.
Cheng, A., Su, I. J., Chen, C. C., et al. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.6.1185 · Cited by 55
Extracorporeal Photopheresis and Recombinant Interferon Alfa 2b in Sezary Syndrome
Vonderheid, E. C., Bigler, R. D., Greenberg, A. S., Neukum, S. J., & Micaily, B. (1994) · American Journal of Clinical Oncology · doi:10.1097/00000421-199406000-00016 · Cited by 54
Bexarotene in the treatment of cutaneous T-cell lymphoma
Querfeld, C., Nagelli, L. V., Rosen, S. T., Kuzel, T. M., & Guitart, J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.7.907 · Cited by 54
Self-citationOrmsby, A., Bergfeld, W. F., Tubbs, R. R., & Hsi, E. D. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.116342 · Cited by 54
Li, J. Y., Pulitzer, M. P., Myskowski, P. L., Dusza, S. W., Horwitz, S. M., Moskowitz, A. J., & Querfeld, C. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.03.036 · Cited by 54
Self-citationQuerfeld, C., Rosen, S. T., Guitart, J., RADEMAKER, A. W., Fung, B. B., Posten, W., & Kuzel, T. M. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.11.058 · Cited by 53
Self-citationAssessment of histologic criteria in the diagnosis of mycosis fungoides
Naraghi, Z. S., Seirafi, H., Valikhani, M., Farnaghi, F., Kavusi, S., & Dowlati, Y. (2003) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2003.01566.x · Cited by 51
Lindae, M. L., Abel, E. A., Hoppe, R. T., & Wood, G. S. (1988) · Archives of Dermatology · doi:10.1001/archderm.1988.01670030032018 · Cited by 50
Jones, G. W., McLean, J., Rosenthal, D., Roberts, J., & Sauder, D. N. (1992) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(92)70142-3 · Cited by 50
Multicenter Photopheresis Intervention Trial in Early-Stage Mycosis Fungoides
Talpur, R., Demierre, M., Geskin, L. J., Baron, E. D., Pugliese, S. B., Eubank, K. V., Zic, J. A., Miller, D. R., Tharp, M. D., Bohjanen, K. A., et al. (2011) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2011.03.003 · Cited by 50
Tsirigotis, P. D., Pappa, V., Papageorgiou, S. G., Kapsimali, V., Giannopoulou, V., Kaitsa, I., Girkas, K., Papageorgiou, E. S., Stavrianeas, N. G., Economopoulos, T., et al. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07901.x · Cited by 50
Mao, X., Orchard, G. E., Vonderheid, E. C., Nowell̀, P. C., Bagot, M., Bensussan, A., Russell‐Jones, R., Young, B. D., & Whittaker, S. J. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700224 · Cited by 47
Extracorporeal Photopheresis for the Treatment of Cutaneous T-Cell Lymphoma
Duvic, M. A., Chiao, N., & Talpur, R. (2003) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/12034754030070s402 · Cited by 46
Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2
Rook, A. H., Kuzel, T. M., & Olsen, E. A. (2003) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(03)00109-6 · Cited by 46
Skin directed therapy for mycosis fungoides: a review.
Berthelot, C., Rivera, A. M., & Duvic, M. (2008) · PubMed · Cited by 41
Different mechanisms of Campath-1H-mediated depletion for CD4+and CD8+T cells in peripheral blood
Lowenstein, H., Shah, A. A., Chant, A., & Khan, A. U. H. (2006) · Transplant International · doi:10.1111/j.1432-2277.2006.00382.x · Cited by 41
Kim, Y. H., Demierre, M., Kim, E. J., Lerner, A., Rook, A. H., Duvic, M. A., Robak, T., Samtsov, A. V., McCulloch, W. F., Chen, S. C., et al. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.711829 · Cited by 41
Subcutaneous alemtuzumab for Sézary Syndrome in the very elderly
Alinari, L., Geskin, L. J., Grady, T., Baiocchi, R. A., Bechtel, M. A., & Porcu, P. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.11.009 · Cited by 39
Payne, C. M. (1986) · Archives of Dermatology · doi:10.1001/archderm.122.10.1139 · Cited by 39
Narrow‐band ultraviolet therapy in early‐stage mycosis fungoides: study on 20 patients
Brazzelli, V., Antoninetti, M., Palazzini, S., Prestinari, F., & Borroni, G. (2007) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.2007.00314.x · Cited by 37
Human Anti-CCR4 Minibody Gene Transfer for the Treatment of Cutaneous T-Cell Lymphoma
Han, T. K., Abdel‐Motal, U. M., Chang, D.-K., Sui, J., Muvaffak, A., Campbell, J. J., Zhu, Q. K., Kupper, T. S., & Marasco, W. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044455 · Cited by 36
Immunomodulation at the initiation of phototherapy and photochemotherapy
Guckian, M., Jones, C. D., Vestey, J. P., Cooper, E. J., Dawe, R. S., Gibbs, N. K., & Norval, M. (1995) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.1995.tb00160.x · Cited by 36
Successful treatment of chemotherapy‐refractory Sézary syndrome with alemtuzumab (Campath‐1H)
Gautschi, O. P., Blumenthal, N., Streit, M., Solenthaler, M., Hunziker, T., & Zenhäusern, R. (2003) · European Journal Of Haematology · doi:10.1046/j.0902-4441.2004.00169.x · Cited by 34
Cited by
Trautinger, F., Eder, J., Assaf, C., Bagot, M., Cozzio, A., Dummer, R., Gniadecki, R., Klemke, C.-D., Ortiz-Romero, P. L., Papadavid, E., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.02.027 · Cited by 452
Retinoic acid receptors: From molecular mechanisms to cancer therapy
di Masi, A., Leboffe, L., De Marinis, E., Pagano, F., Cicconi, L., Rochette-Egly, C., Lo-Coco, F., Ascenzi, P., & Nervi, C. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.003 · Cited by 403
Wang, L., Ni, X., Covington, K. R., Yang, B. Y., Shiu, J., Zhang, X., Xi, L., Meng, Q., Langridge, T., Drummond, J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3444 · Cited by 323
Specht, L., Dabaja, B., Illidge, T., Wilson, L. D., & Hoppe, R. T. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.01.008 · Cited by 227
Mast cell activation disorders
Akin, C. (2014) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2014.03.007 · Cited by 56
Metadata
- Authors
- Jawed, S. I., Myskowski, P. L., Horwitz, S., Moskowitz, A., & Querfeld, C.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 70
- Issue
- 2
- Pages
- 205.e1-205.e16
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2768338596
- Cited by
- 381
- References
- 214
- FWCI
- 39.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.